Overview
An AI drug-discovery company, founded by a co-developer of AlphaFold, the Nobel Prize-winning AI system, had a breakthrough to take to the most important week in its industry's calendar: the J.P. Morgan Healthcare Conference. Weeks before, the company had announced a major result, including success against a target long considered undruggable. JPM was the moment to convert that science into commercial partnerships with the world's leading pharmaceutical companies, in front of an audience of C-suite and business-development leaders rather than the scientists its existing materials had been built for.
The Mandate
VERBED engineered the presentation, from the narrative through the design. Working directly with the founder, we distilled the company's capabilities into a single thesis built around what becomes possible for a partner, anchored by an inspiring opener: "Now you can." The story showed partners what the platform unlocked: moving straight to preclinical development, running more programs with the same resources, and pursuing targets that had been out of reach. That framing turned a technology explanation into a clear articulation of opportunity.
We preserved the deep technical and scientific credibility the work demanded, so the same presentation held up with R&D and technical teams as well as with audiences less familiar with the science. The result was a single, flexible presentation the founder could tailor to each conversation, whether commercial or investor.
Outcome
The presentation positioned the company as a premier AI drug-discovery platform at one of the industry's most competitive events, let one flexible presentation carry both commercial and investor conversations, and worked well enough that the company has since referred VERBED to others.
A public company with billions in market cap at stake
Investor materials for a multi-billion-dollar consumer VC
A confident board update for an uncertain market
From overlooked to 3x oversubscribed
A first fund worthy of a global name
LP materials that raised $190M, 30% over target
From first raise to strategic exit
The M&A package that created millions in accretive value
From wholesaler to scalable platform
The $1.6B presentation
Partnership conversations at the industry's biggest week
A global rebrand and product launch
A decade as an extension of the executive team
A brand from scratch for a Super Bowl champion
Carrying authority into new clinical ground
AGM preparation while the CEO closed multiple acquisitions
